Identification of ANKK1 rs1800497 variant in schizophrenia: New data and meta-analysis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 7, 2014, Pages 564-571

  Zhang, Chen ^a,b   Zhang, Jiangtao ^c   Fan, Juan ^a   Cheng, Wenhong ^a   Du, Yasong ^a   Yu, Shunying ^a   Fang, Yiru ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c Zhejiang Academy of Traditional Chinese Medicine   (China)

Author keywords

Age at onset; ANKK1; Meta analysis; Polymorphism; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ANKYRIN REPEAT AND KINASE DOMAIN CONTAINING 1 GENE; ARTICLE; CAUSAL ATTRIBUTION; CHILD; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); ONSET AGE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SEGREGATION DISTORTION; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PROGNOSIS;

ANKK1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SCHIZOPHRENIA;

EID: 84908265212     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32259     Document Type: Article

References (56)

1. Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40:827-834.
2. Andersen SL, Teicher MH. 2000. Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev 24:137-141.
3. Aslan S, Karaoguz MY, Eser HY, Karaer DK, Taner E. 2010. Comparison of DRD2 rs1800497 (TaqIA) polymorphism between schizophrenic patients and healthy controls: Lack of association in a Turkish sample. Int J Psychiatry Clin Pract 14:257-261.
4. Behravan J, Hemayatkar M, Toufani H, Abdollahian E. 2008. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population. Arch Iran Med 11:252-256.
5. Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT, Vazharova RV, Dimova II, Milanova VK, Tolev T, Kirov G, Owen MJ, O'Donovan MC, Kamatani N, Nakamura Y, Toncheva DI. 2009. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 54:98-107.
6. Brunelin J, Fecteau S, Suaud-Chagny MF. 2013. Abnormal striatal dopamine transmission in schizophrenia. Curr Med Chem 20:397-404.
7. Cai J, Zhang W, Yi Z, Lu W, Wu Z, Chen J, Yu S, Fang Y, Zhang C. 2013. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms. Psychopharmacology 230:49-55.
8. Campion D, d'Amato T, Bastard C, Laurent C, Guedj F, Jay M, Dollfus S, Thibaut F, Petit M, Gorwood P. 1994. Genetic study of dopamine D1, D2, and D4 receptors in schizophrenia. Psychiatry Res 51:215-230.
9. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW, Levy DL, Smith M, Borison RL, Evans DD, Klein DN, Macmurray J, Tosk JM, Sverd J, Gysin R, Flanagan SD. 1991. The dopamine-D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 266:1793-1800.
10. Crowther M, Lim W, Crowther MA. 2010. Systematic review and meta-analysis methodology. Blood 116:3140-3146.
11. Dersimonian R. 1990. Combining evidence from clinical-trials. Anesth Analg 70:475-476.
12. Dollfus S, Campion D, Vasse T, Preterre P, Laurent C, dAmato T, Thibaut F, Mallet J, Petit M. 1996. Association study between dopamine D1, D2, D3, and D4 receptor genes and schizophrenia defined by several diagnostic systems. Biol Psychiatry 40:419-421.
13. Dubertret C, Bardel C, Ramoz N, Martin PM, Deybach JC, Ades J, Gorwood P, Gouya L. 2010. A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes. Prog Neuropsychopharmacol Biol Psychiatry 34:492-499.
14. Dubertret C, Gorwood P, Gouya L, Deybach JC, Ades J. 2001. Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophr Res 49:203-212.
15. Dubertret C, Gouya L, Hanoun N, Deybach JC, Ades J, Hamon M, Gorwood P. 2004. The 3' region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res 67:75-85.
16. Fan JB, Sklar P. 2005. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry 10:928-938.
17. Frangou S, Hadjulis M, Vourdas A. 2008. The Maudsley early onset schizophrenia study: Cognitive function over a 4-year follow-up period. Schizophr Bull 34:52-59.
18. Ghosh J, Pradhan S, Mittal B. 2013. Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility. Neuromolecular Med 15:61-73.
19. Glatt SJ, Faraone SV, Tsuang MT. 2003. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family-based studies. Am J Psychiatry 160:469-476.
20. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF, Herman DH, Clasen LS, Toga AW, Rapoport JL, Thompson PM. 2004. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 101:8174-8179.
21. Guigas B, de Leeuw van Weenen JE, van Leeuwen N, Simonis-Bik AM, van Haeften TW, Nijpels G, Houwing-Duistermaat JJ, Beekman M, Deelen J, Havekes LM, Penninx BW, Vogelzangs N, van 't Riet E, Dehghan A, Hofman A, Witteman JC, Uitterlinden AG, Grarup N, Jorgensen T, Witte DR, Lauritzen T, Hansen T, Pedersen O, Hottenga J, Romijn JA, Diamant M, Kramer MH, Heine RJ, Willemsen G, Dekker JM, Eekhoff EM, Pijl H, de Geus EJ, Slagboom PE, t Hart LM. 2014. Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility. Diabet Med doi: 10.1111/dme.12464
22. Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Yamamori H, Kamino K, Morihara T, Iwase M, Kazui H, Numata S, Ikeda M, Ueno S, Ohmori T, Iwata N, Ozaki N, Takeda M. 2011. No association between the PCM1 gene and schizophrenia: A multi-center case-control study and a meta-analysis. Schizophr Res 129:80-84.
23. Holmen A, Juuhl-Langseth M, Thormodsen R, Melle I, Rund BR. 2010. Neuropsychological profile in early-onset schizophrenia-spectrum disorders: Measured with the MATRICS battery. Schizophr Bull 36:852-859.
24. Jepsen JR, Fagerlund B, Pagsberg AK, Christensen AM, Nordentoft M, Mortensen EL. 2010. Deficient maturation of aspects of attention and executive functions in early onset schizophrenia. Eur Child Adolesc Psychiatry 19:773-786.
25. Jones HM, Pilowsky LS. 2002. Dopamine and antipsychotic drug action revisited. Br J Psychiatry 181:271-275.
26. Jonsson E, Brene S, Geijer T, Terenius L, Tylec A, Persson ML, Sedvall G. 1996. A search for association between schizophrenia and dopamine-related alleles. Eur Arch Psychiatry Clin Neurosci 246:297-304.
27. Kumra S, Charles Schulz S. 2008. Editorial: Research progress in early-onset schizophrenia. Schizophr Bull 34:15-17.
28. Kunii Y, Miura I, Matsumoto J, Hino M, Wada A, Niwa SI, Nawa H, Sakai M, Someya T, Takahashi H, Kakita A, Yabe H. 2014. Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 53C:123-128.
29. Kyriakopoulos M, Dima D, Roiser JP, Corrigall R, Barker GJ, Frangou S. 2012. Abnormal functional activation and connectivity in the working memory network in early-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 51:911-920.
30. Laakso A, Pohjalainen T, Bergman J, Kajander J, Haaparanta M, Solin O, Syvalahti E, Hietala J. 2005. The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics 15:387-391.
31. Lafuente A, Bernardo M, Mas S, Crescenti A, Aparici M, Gasso P, Deulofeu R, Mane A, Catalan R, Carne X. 2008a. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders. Psychiatry Res 161:131-141.
32. Lafuente A, Bernardo M, Mas S, Crescenti A, Aparici M, Gasso P, Goti J, Sanchez V, Catalan R, Carne X. 2008b. -141C Ins/Del polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in a Spanish population. Psychiatr Genet 18:122-127.
33. Monakhov M, Golimbet V, Abramova L, Kaleda V, Karpov V. 2008. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr Res 100:302-307.
34. Neville MJ, Johnstone EC, Walton RT. 2004. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23:540-545.
35. Ni J, Lu W, Wu Z, Chen J, Yi Z, Zhang C. 2013. T102C polymorphism of serotonin 2A type receptor gene confers susceptibility to (early onset) schizophrenia in Han Chinese: An association study and meta-analysis. Asia Pac Psychiatry 5:24-30.
36. Nothen MM, Wildenauer D, Cichon S, Albus M, Maier W, Minges J, Lichtermann D, Bondy B, Rietschel M, Korner J. 1994. Dopamine D2 receptor molecular variant and schizophrenia. Lancet 343:1301-1302.
37. Nyman ES, Loukola A, Varilo T, Taanila A, Hurtig T, Moilanen I, Loo S, McGough JJ, Jarvelin MR, Smalley SL, Nelson SF, Peltonen L. 2012. Sex-specific influence of DRD2 on ADHD-type temperament in a large population-based birth cohort. Psychiatr Genet 22:197-201.
38. Parsons MJ, Mata I, Beperet M, Iribarren-Iriso F, Arroyo B, Sainz R, Arranz MJ, Kerwin R. 2007. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatr Genet 17:159-163.
39. Richter A, Richter S, Barman A, Soch J, Klein M, Assmann A, Libeau C, Behnisch G, Wustenberg T, Seidenbecher CI, Schott BH. 2013. Motivational salience and genetic variability of dopamine D2 receptor expression interact in the modulation of interference processing. Front Hum Neurosci 7:250.
40. Ritchie T, Noble EP. 2003. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 28:73-782.
41. Sanders AR, Rinconlimas DE, Chakraborty R, Grandchamp B, Hamilton JD, Fann WE, Patel PI. 1993. Association between genetic-variation at the porphobilinogen deaminase gene and schizophrenia. Schizophr Res 8:211-221.
42. Savitz J, Hodgkinson CA, Martin-Soelch C, Shen PH, Szczepanik J, Nugent AC, Herscovitch P, Grace AA, Goldman D, Drevets WC. 2013. DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder. Int J Neuropsychopharmacol 16:2095-2101.
43. Sawada H, Shimohama S. 2000. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev 24:143-147.
44. Shi YY, He L. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97-98.
45. Srivastava V, Deshpande SN, Thelma BK. 2010. Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among North Indians. Neuropsychobiology 61:64-70.
46. Vijayan NN, Bhaskaran S, Koshy LV, Natarajan C, Srinivas L, Nair CM, Allencherry PM, Banerjee M. 2007. Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population. Behav Brain Funct 3:34.
47. Wang Z, Li Z, Chen J, Huang J, Yuan C, Hong W, Yu S, Fang Y. 2012. Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population. Genes Brain Behav 11:524-528.
48. Wang ZW, Fan JB, Gao KM, Li ZZ, Yi ZH, Wang LX, Huang J, Yuan CM, Hong W, Yu SY, Fang YR. 2013. Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorder. J Mol Neurosci 50:305-310.
49. Woolf B. 1955. On estimating the relation between blood group and disease. Annals of Human Genetics 19:251-253.
50. Yi Z, Zhang C, Wu Z, Hong W, Li Z, Fang Y, Yu S. 2011. Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population. Brain Res 1417:146-150.
51. Zhang C, Cai J, Zhang JT, Li ZZ, Guo ZW, Zhang X, Lu WH, Zhang Y, Yuan AH, Yu SY, Fang YR. 2014a. Genetic modulation of working memory deficits by ankyrin 3 gene in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 50:110-115.
52. Zhang C, Fang Y, Xie B, Cheng W, Du Y, Wang D, Yu S. 2009. DNA methyltransferase 3B gene increases risk of early onset schizophrenia. Neurosci Lett 462:308-311.
53. Zhang C, Fang YR, Xie B, Cheng WH, Du YS, Wang DX, Yu SY. 2010. No genetic association between dopamine D1 receptor gene and [early onset] schizophrenia. Psychiatry Res 177:350-353.
54. Zhang C, Li Z, Shao Y, Xie B, Du Y, Fang Y, Yu S. 2011. Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. J Mol Neurosci 43:406-411.
55. Zhang C, Li ZZ, Wu ZG, Chen J, Wang ZW, Peng DH, Hong W, Yuan CM, Wang Z, Yu SY, Xu YF, Xu L, Xiao ZP, Fang YR. 2014b. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression. Psychopharmacology 231:685-693.
56. Zhang X, Zhang C, Wu Z, Wang Z, Peng D, Chen J, Hong W, Yuan C, Li Z, Yu S, Fang Y. 2013. Association of genetic variation in CACNA1C with bipolar disorder in Han Chinese. J Affect Disord 150:261-265.